![KN495 updated clinical manuscript entitled “Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results” has been epublished by Nature Medicine on July 10](https://oncodaily.com/pub/uploads/2023/07/Jianda-Yuan-1-1280x720.jpeg)
Photo from Jianda Yuan/Linkedin
Jul 17, 2023, 07:12
KN495 updated clinical manuscript entitled “Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results” has been epublished by Nature Medicine on July 10
In a post by
Attached and available through the link please find the ePublished version for your reference: https://lnkd.in/ewdfhzE6